Serum carbohydrate antigen 19-9 represents a marker of response to neoadjuvant therapy in patients with borderline resectable pancreatic cancer

✍ Scribed by Tzeng, Ching-Wei D.; Balachandran, Aparna; Ahmad, Mediha; Lee, Jeffrey E.; Krishnan, Sunil; Wang, Huamin; Crane, Christopher H.; Wolff, Robert A.; Varadhachary, Gauri R.; Pisters, Peter W. T.; Aloia, Thomas A.; Vauthey, Jean-Nicolas; Fleming, Jason B.; Katz, Matthew H. G.

• Book ID: 125475799
• Publisher: John Wiley and Sons
• Year: 2014
• Tongue: English
• Weight: 264 KB
• Volume: 16
• Category: Article
• ISSN: 1365-182X
• DOI: 10.1111/hpb.12154